288 related articles for article (PubMed ID: 25281742)
1. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.
Eriksson O; Ramström M; Hörnaeus K; Bergquist J; Mokhtari D; Siegbahn A
J Biol Chem; 2014 Nov; 289(47):32379-91. PubMed ID: 25281742
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer.
Eriksson O; Thulin Å; Asplund A; Hegde G; Navani S; Siegbahn A
BMC Cancer; 2016 May; 16():341. PubMed ID: 27246245
[TBL] [Abstract][Full Text] [Related]
3. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
4. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
Poulsen LK; Jacobsen N; Sørensen BB; Bergenhem NC; Kelly JD; Foster DC; Thastrup O; Ezban M; Petersen LC
J Biol Chem; 1998 Mar; 273(11):6228-32. PubMed ID: 9497347
[TBL] [Abstract][Full Text] [Related]
6. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
7. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.
Disse J; Petersen HH; Larsen KS; Persson E; Esmon N; Esmon CT; Teyton L; Petersen LC; Ruf W
J Biol Chem; 2011 Feb; 286(7):5756-67. PubMed ID: 21149441
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
9. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
Rothmeier AS; Versteeg HH; Ruf W
J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
[TBL] [Abstract][Full Text] [Related]
10. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC
J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.
Mandal SK; Pendurthi UR; Rao LV
Blood; 2007 Jul; 110(1):161-70. PubMed ID: 17384202
[TBL] [Abstract][Full Text] [Related]
14. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
[TBL] [Abstract][Full Text] [Related]
15. Factor VII mutant V154G models a zymogen-like form of factor VIIa.
Toso R; Bernardi F; Tidd T; Pinotti M; Camire RM; Marchetti G; High KA; Pollak ES
Biochem J; 2003 Feb; 369(Pt 3):563-71. PubMed ID: 12358603
[TBL] [Abstract][Full Text] [Related]
16. The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.
Wagner MJ; Hsiung MS; Gish GD; Bagshaw RD; Doodnauth SA; Soliman MA; Jørgensen C; Tucholska M; Rottapel R
J Biol Chem; 2020 Mar; 295(12):3932-3944. PubMed ID: 32060095
[TBL] [Abstract][Full Text] [Related]
17. An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates.
Fiore MM; Neuenschwander PF; Morrissey JH
Blood; 1992 Dec; 80(12):3127-34. PubMed ID: 1467519
[TBL] [Abstract][Full Text] [Related]
18. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
19. TF:FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2.
Versteeg HH; Borensztajn KS; Kerver ME; Ruf W; Reitsma PH; Spek CA; Peppelenbosch MP
J Thromb Haemost; 2008 Sep; 6(9):1550-7. PubMed ID: 18647225
[TBL] [Abstract][Full Text] [Related]
20. Cellular consequences upon factor VIIa binding to tissue factor.
Siegbahn A
Haemostasis; 2000; 30 Suppl 2():41-7. PubMed ID: 11251340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
